MHRA fast-tracks pill to prevent pre-eclampsia 9 Nov 2022

MHRA fast-tracks pill to prevent pre-eclampsia

Scientists at MirZyme Therapeutics believe they have developed a drug that, when given to women from 20 weeks of pregnancy, could stop them developing the condition.

 This news comes in the same week that MirZyme’s executive chair, Prof Asif Ahmed, will be attending the Birmingham Awards, where he has been shortlisted for the Businessman of the Year award. PharmaMedic Consultancy’s Managing Director Malcolm Barratt-Johnson will be attending the event on 11 November to support Prof Ahmed, as he is on the MirZyme Therapeutics board.

Read more about the pre-eclampsia pill here.